Patent Assignment
Reel/Frame 024380/0824
Merger
Recorded: 2010-05-14
Pages: 10
Assignor
PROTEOLIX, INC.
Executed: 2009-11-16
Assignee
ONYX THERAPEUTICS, INC.
333 ALLERTON AVENUE, SOUTH SAN FRANCISCO, CALIFORNIA, 94080
Covered Properties
(12)
Compounds for Enzyme Inhibition
Compounds for Enzyme Inhibition
Novel Substrate for RPN11 Enzymatic Activity
Compounds for Enzyme Inhibition
Compounds for Enzyme Inhibition
Compounds for Enzyme Inhibition
Compounds for Proteasome Enzyme Inhibition
Compounds for Enzyme Inhibition
Compounds for Enzyme Inhibition
Crystalline Peptide Epoxy Ketone Protease Inhibitors and the Synthesis of Amino Acid Keto-Epoxides
Compounds for Enzyme Inhibition
Application:
12/434,185 →
Publication:
US 2009/0215093
Novel Substrate for Rpn 11 Enzymatic Activity
Related Assignments
(3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Sep 26, 2008
From: SMYTH, MARK S.; LAIDIG, GUY J.
To: PROTEOLIX, INC.
Reel/Frame 021594/0964 →
Assignment of Assignor's Interest
Dec 2, 2008
From: PHIASIVONGSA, PASIT; SEHL, LOUIS C.; FULLER, WILLIAM DEAN; LAIDIG, GUY J.
To: PROTEOLIX, INC.
Reel/Frame 021916/0900 →
Change of Address of the Assignee
Nov 2, 2016
From: ONYX THERAPEUTICS, INC.
To: ONYX THERAPEUTICS, INC.
Reel/Frame 040878/0943 →